Steve Lichtman

In the U.S., what are you seeing on price? I know you've been conservative on that

Can you talk about the opportunities you see to build on the MiSight platform from an innovation perspective?

I was wondering if you could talk to what you are expecting for price in your contact lens business this year. And has some of the softening consumer sentiment created any pushback to date?

where will we see some of that headwind? Will it be on gross margin again on a reported basis

How should we be thinking about that into FY'25? Will you see any relief on CapEx

How would you have us think about the underlying international growth outlook here in the near to medium term? And what are the biggest incremental catalysts outside of the U.S.

Can you talk about what the forms of that -- what that might look like? Is it solely direct-to-patient work

are you thinking about that messaging changing over the next couple years

Can you delve click on the DTC efforts? How deep are you into that work? Can you talk about sort of any return

I'm wondering what kind of response you've gotten as you've talked to customers

Do you think it can be in that 70% to 80%

Can you talk about how much sales vicinity you're assuming as a result? And I know you mentioned still double-digit growth

can we still expect the impact all in the second half? Was there anything in 2Q?

where do you think we are at on underlying hip and knee market growth

I was wondering if you could talk about guidance cadence a bit more for the year excluding Paragon